Organization
Imara
5 clinical trials
Clinical trial
A Phase 2b Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects With Sickle Cell DiseaseStatus: Terminated, Estimated PCD: 2022-03-02
Clinical trial
A Phase 2 Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects With Beta ThalassemiaStatus: Terminated, Estimated PCD: 2022-03-11
Clinical trial
A Phase 1a Study of IMR-687 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2017-07-08
Clinical trial
Selective PDE9 Inhibition With IMR-687 in Adults With Heart Failure With Preserved Ejection Fraction: a Safety and Efficacy Phase 2 Randomized Clinical Study (SP9In-HFpEF)Status: Withdrawn, Estimated PCD: 2023-09-01
Clinical trial
A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study of IMR-687 in Adult Patients With Sickle Cell Anaemia (Homozygous HbSS or Sickle-β0 Thalassemia)Status: Completed, Estimated PCD: 2020-08-28